ナルコレプシー治療薬の世界市場 2024-2028

ナルコレプシー治療薬市場は2023-2028年に18億660万米ドル、予測期間中のCAGRは10.03%で成長すると予測されています。

当レポートでは、ナルコレプシー治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、製品の上市や臨床試験の増加、成人のナルコレプシー症例の増加、ナルコレプシーの原因や治療法を解明するための研究数の増加によって牽引されています。

本調査では、今後数年間のナルコレプシー治療薬市場成長を牽引する主要因の1つとして、ナルコレプシー治療の進歩を挙げています。また、ナルコレプシーに対する非薬物療法や併用療法に対する需要の増加が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界ナルコレプシー治療薬市場 2018-2022
• タイプ別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメンテーション
• 比較：タイプ別
• 脱力発作を伴うナルコレプシー：市場規模と予測 2023-2028
• 脱力発作を伴わないナルコレプシー：市場規模と予測 2023-2028
• 二次性ナルコレプシー：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 顧客情勢

• 顧客情勢の概要

第8章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第9章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第10章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第11章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Alkermes Public Ltd. Co.
• Avadel Pharmaceuticals plc
• Axsome Therapeutics Inc.
• BIOPROJET
• Jazz Pharmaceuticals Plc
• SHIONOGI Co. Ltd.
• Somacare
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• XWPharma Ltd.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Parent Market
• Exhibits10: Data Table on - Parent Market
• Exhibits11: Market characteristics analysis
• Exhibits12: Value Chain Analysis
• Exhibits13: Offerings of companies included in the market definition
• Exhibits14: Market segments
• Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Historic Market Size - Data Table on Global Narcolepsy Drugs Market 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Narcolepsy with cataplexy - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Narcolepsy with cataplexy - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Narcolepsy with cataplexy - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Narcolepsy with cataplexy - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Narcolepsy without cataplexy - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Narcolepsy without cataplexy - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Narcolepsy without cataplexy - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Narcolepsy without cataplexy - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Secondary narcolepsy - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Secondary narcolepsy - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Secondary narcolepsy - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Secondary narcolepsy - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Type ($ million)
• Exhibits47: Data Table on Market opportunity by Type ($ million)
• Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits51: Chart on Geographic comparison
• Exhibits52: Data Table on Geographic comparison
• Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits89: Market opportunity By Geographical Landscape ($ million)
• Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits91: Impact of drivers and challenges in 2023 and 2028
• Exhibits92: Overview on criticality of inputs and factors of differentiation
• Exhibits93: Overview on factors of disruption
• Exhibits94: Impact of key risks on business
• Exhibits95: Companies covered
• Exhibits96: Matrix on companies position and classification
• Exhibits97: Alkermes Public Ltd. Co. - Overview
• Exhibits98: Alkermes Public Ltd. Co. - Product / Service
• Exhibits99: Alkermes Public Ltd. Co. - Key offerings
• Exhibits100: Avadel Pharmaceuticals plc - Overview
• Exhibits101: Avadel Pharmaceuticals plc - Product / Service
• Exhibits102: Avadel Pharmaceuticals plc - Key offerings
• Exhibits103: Axsome Therapeutics Inc. - Overview
• Exhibits104: Axsome Therapeutics Inc. - Product / Service
• Exhibits105: Axsome Therapeutics Inc. - Key offerings
• Exhibits106: BIOPROJET - Overview
• Exhibits107: BIOPROJET - Product / Service
• Exhibits108: BIOPROJET - Key offerings
• Exhibits109: Jazz Pharmaceuticals Plc - Overview
• Exhibits110: Jazz Pharmaceuticals Plc - Product / Service
• Exhibits111: Jazz Pharmaceuticals Plc - Key news
• Exhibits112: Jazz Pharmaceuticals Plc - Key offerings
• Exhibits113: SHIONOGI Co. Ltd. - Overview
• Exhibits114: SHIONOGI Co. Ltd. - Product / Service
• Exhibits115: SHIONOGI Co. Ltd. - Key offerings
• Exhibits116: Somacare - Overview
• Exhibits117: Somacare - Product / Service
• Exhibits118: Somacare - Key offerings
• Exhibits119: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits120: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits123: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits124: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits125: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits126: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits127: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits128: XWPharma Ltd. - Overview
• Exhibits129: XWPharma Ltd. - Product / Service
• Exhibits130: XWPharma Ltd. - Key offerings
• Exhibits131: Inclusions checklist
• Exhibits132: Exclusions checklist
• Exhibits133: Currency conversion rates for US$
• Exhibits134: Research methodology
• Exhibits135: Information sources
• Exhibits136: Data validation
• Exhibits137: Validation techniques employed for market sizing
• Exhibits138: Data synthesis
• Exhibits139: 360 degree market analysis
• Exhibits140: List of abbreviations

The narcolepsy drugs market is forecasted to grow by USD 1806.6 mn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the narcolepsy drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising product launches and clinical trials, rising cases of narcolepsy in adults, and rising number of studies to understand cause and treatment of narcolepsy.

Technavio's narcolepsy drugs market is segmented as below:

By Type

• Narcolepsy with cataplexy
• Narcolepsy without cataplexy
• Secondary narcolepsy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancement in narcolepsy treatment as one of the prime reasons driving the narcolepsy drugs market growth during the next few years. Also, increasing demand for non-pharmacological therapies and combination treatments for narcolepsy will lead to sizable demand in the market.

The report on the narcolepsy drugs market covers the following areas:

• Narcolepsy drugs market sizing
• Narcolepsy drugs market forecast
• Narcolepsy drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading narcolepsy drugs market vendors that include Alkermes Public Ltd. Co., Apotex Inc., Aurobindo Pharma Ltd., Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., BIOPROJET, Cadila Pharmaceuticals Ltd., Don Valley Pharma, Graymark Healthcare Inc., Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals Plc, Luckys Pharma Pvt. Ltd., Midas Pharma GmbH, Orbion Pharmaceuticals Pvt. Ltd., SHIONOGI Co. Ltd., Somacare, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and XWPharma Ltd.. Also, the narcolepsy drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Narcolepsy Drugs Market 2018 - 2022
  • Historic Market Size - Data Table on Global Narcolepsy Drugs Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Narcolepsy with cataplexy - Market size and forecast 2023-2028
  • Chart on Narcolepsy with cataplexy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Narcolepsy with cataplexy - Market size and forecast 2023-2028 ($ million)
  • Chart on Narcolepsy with cataplexy - Year-over-year growth 2023-2028 (%)
  • Data Table on Narcolepsy with cataplexy - Year-over-year growth 2023-2028 (%)
• 6.4 Narcolepsy without cataplexy - Market size and forecast 2023-2028
  • Chart on Narcolepsy without cataplexy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Narcolepsy without cataplexy - Market size and forecast 2023-2028 ($ million)
  • Chart on Narcolepsy without cataplexy - Year-over-year growth 2023-2028 (%)
  • Data Table on Narcolepsy without cataplexy - Year-over-year growth 2023-2028 (%)
• 6.5 Secondary narcolepsy - Market size and forecast 2023-2028
  • Chart on Secondary narcolepsy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Secondary narcolepsy - Market size and forecast 2023-2028 ($ million)
  • Chart on Secondary narcolepsy - Year-over-year growth 2023-2028 (%)
  • Data Table on Secondary narcolepsy - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 8.11 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 Alkermes Public Ltd. Co.
  • Alkermes Public Ltd. Co. - Overview
  • Alkermes Public Ltd. Co. - Product / Service
  • Alkermes Public Ltd. Co. - Key offerings
• 11.4 Avadel Pharmaceuticals plc
  • Avadel Pharmaceuticals plc - Overview
  • Avadel Pharmaceuticals plc - Product / Service
  • Avadel Pharmaceuticals plc - Key offerings
• 11.5 Axsome Therapeutics Inc.
  • Axsome Therapeutics Inc. - Overview
  • Axsome Therapeutics Inc. - Product / Service
  • Axsome Therapeutics Inc. - Key offerings
• 11.6 BIOPROJET
  • BIOPROJET - Overview
  • BIOPROJET - Product / Service
  • BIOPROJET - Key offerings
• 11.7 Jazz Pharmaceuticals Plc
  • Jazz Pharmaceuticals Plc - Overview
  • Jazz Pharmaceuticals Plc - Product / Service
  • Jazz Pharmaceuticals Plc - Key news
  • Jazz Pharmaceuticals Plc - Key offerings
• 11.8 SHIONOGI Co. Ltd.
  • SHIONOGI Co. Ltd. - Overview
  • SHIONOGI Co. Ltd. - Product / Service
  • SHIONOGI Co. Ltd. - Key offerings
• 11.9 Somacare
  • Somacare - Overview
  • Somacare - Product / Service
  • Somacare - Key offerings
• 11.10 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11.11 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
• 11.12 XWPharma Ltd.
  • XWPharma Ltd. - Overview
  • XWPharma Ltd. - Product / Service
  • XWPharma Ltd. - Key offerings

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations